PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Helena Serra(Institut d'Investigació Biomédica de Bellvitge), Mariona Graupera(Josep Carreras Leukaemia Research Institute), Marcus Fruttiger(UK Biobank), Marcos Malumbres(Institució Catalana de Recerca i Estudis Avançats), Arkaitz Carracedo(Ikerbasque), Francesc Viñals(Bellvitge University Hospital), Ana Angulo‐Urarte(Institut d'Investigació Biomédica de Bellvitge), Oriol Casanovas(Institut Català d'Oncologia), Michael Potente(Max Delbrück Center), Manuel Serrano(Spanish National Cancer Research Centre), Radiance Lim(Max Planck Institute for Heart and Lung Research), Àngels Fabra(Duran i Reynals Hospital), Anna Bigas(Hospital Del Mar), James D. Sutherland(CIC bioGUNE), Holger Gerhardt(Max Delbrück Center), Íñigo Chivite(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Adriana Soler(Institut d'Investigació Biomédica de Bellvitge), Amaia Arruabarrena-Aristorena(CIC bioGUNE), Anan Ragab(Cancer Research UK), Pier Paolo Pandolfi(University of Turin)
Cited by 109
Related Papers
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
|Cancer Cell|2009|2.3k
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
|Cancer Cell|2005|1.6k
A p16 <sup>INK4a</sup> -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
|Science|1995|1.1k
Pten Dose Dictates Cancer Progression in the Prostate
|PLoS Biology|2003|667